AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Sitagliptin & Metformin Hydrochloride

11 registrations across 3 African markets— 11 active

Markets with Sitagliptin & Metformin Hydrochloride

Recent registrations

Brand / ProductMarketHolderStatusExpires
GLUSIMET TABLETS (Each film-coated tablet contains Sitagliptin / Metformin Hydrochloride 50/1000mg)🇬🇭GhanaactiveDec 2030
GLUSIMET TABLETS (Each film-coated tablet contains Sitagliptin / Metformin Hydrochloride 50/500mg)🇬🇭GhanaactiveDec 2030
GLUSIMET TABLETS (Each film-coated tablet contains Sitagliptin / Metformin Hydrochloride 50/500mg)🇬🇭GhanaactiveDec 2030
GLUSIMET TABLETS (Each film-coated tablet contains Sitagliptin / Metformin Hydrochloride 50/1000mg)🇬🇭GhanaactiveDec 2030
GLUSITA PLUS 50/500 mg🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveFeb 2028
GLUSITA PLUS 50/850 mg🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveFeb 2028
GLUSITA PLUS 50/1 000 mg🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveFeb 2028
JOSISITIN PLUS 50/500 mg🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveFeb 2028
JOSISITIN PLUS 50/1 000 mg🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveFeb 2028
JOSISITIN PLUS 50/850 mg🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveFeb 2028
ESGLIP-M 1000
Film-Coated Tablet
🇰🇪KenyaMEDISEL KENYA LIMITEDactiveMar 2027

Sitagliptin & Metformin Hydrochloride in Africa — Regulatory Overview

Sitagliptin & Metformin Hydrochloride is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Kenya. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.